Adaptimmune Therapeutics Plc Il valore contabile della azione
Cos'è Il valore contabile della azione di Adaptimmune Therapeutics Plc?
Il valore contabile della azione di Adaptimmune Therapeutics Plc è 0.19
Qual è la definizione di Il valore contabile della azione?
Il valore contabile per azione è l'asset di una società meno le passività diviso per il numero di azioni in circolazione.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Il valore contabile della azione di aziende nel Health Care settore su NASDAQ rispetto a Adaptimmune Therapeutics Plc
Cosa fa Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Aziende con il valore contabile della azione simili a Adaptimmune Therapeutics Plc
- Red 5 ha Il valore contabile della azione di 0.19
- Whispir ha Il valore contabile della azione di 0.19
- Thunderbird Resorts ha Il valore contabile della azione di 0.19
- Kutcho Copper ha Il valore contabile della azione di 0.19
- Tisdale Resources ha Il valore contabile della azione di 0.19
- WAC ha Il valore contabile della azione di 0.19
- Adaptimmune Therapeutics Plc ha Il valore contabile della azione di 0.19
- RENHENG Enterprise ha Il valore contabile della azione di 0.19
- Tysan ha Il valore contabile della azione di 0.19
- Synairgen plc ha Il valore contabile della azione di 0.19
- Ambition ha Il valore contabile della azione di 0.19
- Stuhini Exploration ha Il valore contabile della azione di 0.19
- Ethos Gold ha Il valore contabile della azione di 0.19